Bayer Cropscience (BAYERCROP.NS) Stock Price

Currency:

Bayer Cropscience Price

🇮🇳NSE·CLOSED

4,672.40INR

Market closed

Today +/-

-5.70 INR

Today %

-0.12 %

PRO

Bayer Cropscience stock price

Ex-Dividend

Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Bayer Cropscience over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Bayer Cropscience stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Bayer Cropscience's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Bayer Cropscience Stock Price History

Date	Bayer Cropscience Price
2/27/2026	4,672.40 INR
2/26/2026	4,678.10 INR
2/25/2026	4,734.00 INR
2/23/2026	4,786.00 INR
2/20/2026	4,800.00 INR
2/19/2026	4,779.80 INR
2/18/2026	4,830.00 INR
2/17/2026	4,758.00 INR
2/16/2026	4,670.00 INR
2/13/2026	4,795.00 INR
2/12/2026	4,810.30 INR
2/11/2026	4,780.00 INR
2/10/2026	4,699.90 INR
2/9/2026	4,611.00 INR
2/6/2026	4,480.00 INR
2/5/2026	4,458.10 INR
2/4/2026	4,484.00 INR
2/3/2026	4,415.40 INR
2/2/2026	4,424.70 INR

API Docs Get API Key

Bayer Cropscience Revenue, EBIT, Net Income

3 Years
5 Years
10 Years
25 Years
Max

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

Revenue

EBIT

Net Income

Details

API Docs Get API Key

Bayer Cropscience Income Statement, Balance Sheet, Cash Flow Statement

Last updated Mar 3, 2026, 12:14 PM

REVENUE (B INR)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (B INR)

NET INCOME (B INR)

NET INCOME GROWTH (%)

DIVIDEND (INR)DIV. (INR)

DIVIDEND GROWTH (%)DIV. GROWTH (%)

SHARES (M)

DOCUMENTS

1999	2000	2001	2002	2003	2004	2005	2006	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e	2027e	2028e
5.96	6.24	7	5.8	8.92	7.52	7.15	7.75	12.38	14.83	17.24	21.37	22.72	27.25	32.45	37.23	28.89	29.48	27.49	31.67	36.09	42.61	47.34	51.4	51.03	54.73	57.7	63.24	69.37
–	4.65	12.25	-17.14	53.64	-15.69	-4.88	8.34	59.86	19.73	16.29	23.97	6.32	19.94	19.08	14.73	-22.40	2.04	-6.76	15.22	13.96	18.06	11.10	8.56	-0.71	7.25	5.41	9.61	9.69
43.91	41.56	39.07	47.98	46.66	44.39	46.80	41.84	38.24	39.85	38.25	35.34	35.66	35.75	35.30	35.05	40.97	39.14	40.24	46.89	46.27	41.85	43.00	44.22	41.97	36.93	35.03	31.96	29.14
2.62	2.59	2.74	2.78	4.16	3.34	3.35	3.24	4.74	5.91	6.6	7.55	8.1	9.74	11.45	13.05	11.84	11.54	11.06	14.85	16.7	17.83	20.36	22.73	21.42	20.21	20.21	20.21	20.21
0.05	0.07	0.09	0.16	0.33	0.32	0.38	0.57	0.49	0.95	1.27	1.32	1.39	11.62	2.9	3.83	3.15	2.91	3	3.37	4.75	4.93	6.45	7.58	7.41	5.68	6.5	7.54	8.57
–	46.00	26.03	68.48	111.61	-3.96	21.59	48.56	-13.71	92.46	34.71	3.38	5.62	735.76	-75.08	32.30	-17.73	-7.65	3.13	12.33	40.76	3.92	30.87	17.50	-2.33	-23.30	14.45	15.92	13.73
-	-	-	-	-	-	-	-	-	-	4.00	4.00	4.20	5.00	9.50	17.00	34.00	17.00	18.00	18.00	115.00	150.00	50.00	135.00	125.00	125.00	125.00	180.95	203.37
–	–	–	–	–	–	–	–	–	–	–	–	5.00	19.05	90.00	78.95	100.00	-50.00	5.88	–	538.89	30.43	-66.67	170.00	-7.41	–	–	44.76	12.39
16	16	16	16	30	39	39	39	39	39	39	39	39	39	39	37	36	35	35	34	45	45	45	44.94	44.94	44.94	44.94	44.94	44.94
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Bayer Cropscience generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Bayer Cropscience retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Bayer Cropscience's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Bayer Cropscience has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Bayer Cropscience's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

ASSETS

CASH BALANCE (B INR)

RECEIVABLES (B INR)

OTHER RECEIVABLES (B INR)OTHER REC. (B INR)

INVENTORIES (B INR)

OTHER CURRENT ASSETS (B INR)OTHER CURRENT LIAB. (B INR)

CURRENT ASSETS (B INR)

TANGIBLE ASSETS (B INR)

LONG-TERM INVESTMENTS (M INR)LONG-T. INVEST. (M INR)

LONG-TERM RECEIVABLES (M INR)LONG-T. REC. (M INR)

INTANGIBLE ASSETS (B INR)INTANGIBLE ASSETS (B INR)

GOODWILL (M INR)

OTHER NON-CURRENT ASSETS (B INR)OTHER NON-CURRENT ASSETS (B INR)

NON-CURRENT ASSETS (B INR)

TOTAL ASSETS (B INR)

LIABILITIES

COMMON STOCK (M INR)

ADDITIONAL PAID-IN CAPITAL (B INR)

RETAINED EARNINGS (B INR)

OTHER EQUITY (M INR)OTHER EQUITY (M INR)

UNREALIZED GAINS/LOSSES (M INR)UNREAL. GAINS/LOSSES (M INR)

EQUITY (B INR)

LIABILITIES (B INR)

PROVISIONS (M INR)

OTHER SHORT-TERM LIABILITIES (B INR)OTHER SHORT-TERM LIAB. (B INR)

SHORT-TERM DEBTS (B INR)SHORT-TERM DEBTS (B INR)

SHORT-TERM PORTION OF LONG-TERM DEBTS (M INR)LONG-TERM DEBT PORTION (M INR)

SHORT-TERM RECEIVABLES (B INR)SHORT-TERM REC. (B INR)

LONG-TERM LIABILITIES (B INR)LONG-T. LIAB. (B INR)

DEFERRED TAXES (M INR)

OTHER LIABILITIES (B INR)OTHER LIAB. (B INR)

LONG-TERM LIABILITIES (B INR)LONG-T. LIABILITIES (B INR)

DEBT (B INR)

TOTAL CAPITAL (B INR)

1999	2000	2001	2002	2003	2004	2005	2006	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025

0.4	0.35	0.34	0.08	0.84	0.53	0.32	0.27	0.27	0.18	0.15	3.63	4.29	9.73	4.86	11.55	7.99	8.88	4.17	5.78	11.08	12.57	8.19	9.02	12.11	9.21
0.95	0.91	0.95	0.95	2.48	1.5	1.71	2.14	1.81	2	1.98	2.81	2.56	3.22	4.1	4.82	4.05	5.57	6.59	6.99	7.18	7.55	10.05	9.77	9.63	9.54
0.39	0.53	0.43	0.38	0.48	0.62	0.6	0.48	0.51	0.58	0.36	0.06	1.72	1.59	3.68	0.59	0.87	0.99	0.5	2.63	1.45	1.44	1.25	1.07	0.93	1.36
0.97	1.04	0.68	1.11	1.42	1.36	1.78	1.89	2.02	3.24	3.48	4.37	5	5	5.5	5.9	6.68	7.75	7.51	11.8	9.87	13.57	15.47	18.32	15.86	23.99
0	0	0	0	0	0.01	0.04	0.04	0.55	0.44	0.82	0.39	1.41	0.37	0.4	0.6	0.63	0.56	1.99	0.61	0.56	0.32	0.8	0.78	0.54	0.62
2.7	2.82	2.41	2.52	5.22	4.01	4.44	4.81	5.16	6.43	6.79	11.27	14.98	19.92	18.53	23.45	20.22	23.74	20.76	27.8	30.14	35.44	35.76	38.96	39.06	44.72
1.14	1.24	1.34	1.38	1.76	1.47	1.69	1.55	2.48	2.7	3.19	3.5	2.53	3.43	4.43	2.93	2.95	3.06	3.01	4.14	4.4	4.01	4.5	4.31	3.83	4.27
39	42	37	37	39	127	40	40	603	102	628	36	36	37	34	317	312	307	302	309	305	300	261	256	251	246
0	0	0	0	0	0	0	0	0	0	0	589	720	734	597	119	159	182	194	364	237	189	98	120	309	420
0	0	0	0	0	0	0	0	0	0	0.02	0.04	0.04	0.03	0.02	0.01	0.13	0.29	0.39	0.43	0.54	0.7	0.89	1.15	1.25	1.36
0	0	0	0	62	31	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	-0.12	0	0.07	0.06	0.01	0.18	0.31	0.28	0.2	0.16	0.1	0	0.26	0.67	0.61	0.67	0.69	2.46	2.73	1.76	2.02	1.99	1.28	1.44
1.18	1.28	1.26	1.42	1.93	1.68	1.73	1.78	3.39	3.08	4.04	4.33	3.43	4.23	5.34	4.05	4.15	4.51	4.59	7.69	8.21	6.95	7.77	7.82	6.92	7.74
3.87	4.1	3.66	3.93	7.15	5.69	6.18	6.59	8.55	9.51	10.83	15.6	18.41	24.15	23.87	27.5	24.37	28.25	25.35	35.49	38.36	42.39	43.53	46.79	45.97	52.46

162	162	162	162	395	395	395	395	395	395	395	395	395	395	366	366	354	354	343	449	449	449	449	449	449	449
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.39	1.39	1.39	1.39	1.39	1.39	1.39
0.65	0.69	0.6	0.72	2	2.22	2.5	2.92	3.3	4.12	5.2	6.34	7.53	18.92	17.06	20.74	18.04	20.21	17.44	20.55	23.88	23.66	23.4	25.28	26.65	26.66
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.82	0.85	0.77	0.88	2.4	2.61	2.9	3.31	3.69	4.51	5.6	6.73	7.93	19.31	17.42	21.11	18.39	20.57	17.78	22.39	25.73	25.5	25.24	27.17	28.49	28.5
0	0	0.01	0.02	0.08	0.01	0.01	1.61	3.06	3.36	2.64	2.95	2.61	1.97	2.87	2.06	2.04	2.87	2.84	6.44	4.75	8.3	8.2	8.73	6.05	10.98
66	52	40	13	12	15	16	20	21	27	28	239	317	375	452	0	0	0	0	0	0	0	0	5	8	19
0.86	0.73	1.14	1.27	2.19	2.25	2.05	0.41	0.94	1.06	1.29	1.79	7.2	2.01	2.62	3.64	3.18	3.96	3.78	5.44	6.33	7.28	8.05	8.67	9.65	10.8
0.27	0.37	0.15	0.16	0.21	0	0	0	0	0	0	1.09	0	0	0	0	0	0	0	0	0.02	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	297	122	346	371	261	435
1.19	1.15	1.33	1.47	2.49	2.28	2.08	2.04	4.02	4.44	3.96	6.07	10.12	4.36	5.95	5.69	5.22	6.83	6.62	11.88	11.39	15.71	16.59	17.78	15.97	22.24
1.9	2.11	1.57	1.48	2.26	0.8	1.21	1.08	0.69	0.43	1.14	0	0	0	0	0	0	0	0	0	0.14	0.14	0.52	0.36	0.21	0.62
0	0	0	111	0	0	0	158	143	133	136	0	0	18	0	0	0	20	104	0	0	0	0	3	40	0
-0.03	-0.02	0	0	0	0	0	0	0	0	0	2.8	0.36	0.46	0.5	0.7	0.75	0.84	0.84	1.22	1.1	1.04	1.18	1.52	1.25	1.1
1.87	2.1	1.57	1.59	2.26	0.8	1.21	1.24	0.84	0.56	1.28	2.8	0.36	0.48	0.5	0.7	0.75	0.86	0.95	1.22	1.24	1.18	1.69	1.89	1.5	1.72
3.06	3.25	2.9	3.05	4.76	3.08	3.28	3.28	4.85	5	5.23	8.87	10.48	4.84	6.45	6.39	5.97	7.69	7.57	13.1	12.63	16.89	18.29	19.67	17.48	23.96
3.88	4.1	3.66	3.93	7.15	5.69	6.18	6.59	8.55	9.51	10.83	15.6	18.41	24.15	23.87	27.5	24.37	28.25	25.35	35.49	38.36	42.39	43.53	46.84	45.97	52.46

Details

Balance Sheet

ⓘ

What Is the Balance Sheet?

The balance sheet is a financial snapshot of Bayer Cropscience at a specific point in time. It follows the fundamental equation: Assets = Liabilities + Shareholders' Equity. Unlike the income statement (which covers a period), the balance sheet tells you what the company owns, what it owes, and what belongs to shareholders at a given date.

Assets

Current assets (cash, receivables, inventory) can be converted to cash within 12 months and indicate short-term liquidity. Non-current assets (property, equipment, intangible assets, goodwill) represent long-term investments. A high proportion of cash and short-term investments gives Bayer Cropscience financial flexibility to weather downturns, fund acquisitions, or return capital to shareholders.

Liabilities

Current liabilities (accounts payable, short-term debt) are obligations due within one year. Non-current liabilities (long-term debt, pension obligations) are due further out. Key ratio to watch: the debt-to-equity ratio (Total Debt ÷ Shareholders' Equity). A ratio below 1.0 is generally healthy, meaning the company is funded more by equity than debt. Highly leveraged companies amplify both gains and losses.

Shareholders' Equity

Equity is the residual value belonging to shareholders after all debts are paid. It includes retained earnings (accumulated profits not paid out as dividends) and paid-in capital. Rising equity year over year is a positive sign — it means Bayer Cropscience is building book value. Declining equity, especially when driven by losses or heavy share buybacks funded by debt, warrants closer scrutiny.

Key Ratios to Derive

From the balance sheet, you can calculate the current ratio (current assets ÷ current liabilities; above 1.5 is comfortable), book value per share (equity ÷ shares outstanding), and return on equity (net income ÷ equity; above 15 % is strong). Tracking these ratios over time reveals whether Bayer Cropscience is strengthening or weakening its financial position.

NET INCOME (B INR)

DEPRECIATION AND AMORTIZATION M INRDEPRECIATION (M INR)

DEFERRED TAXES (M INR)

CHANGES IN WORKING CAPITAL (B INR)CHANGES IN WORKING CAPITAL (B INR)

NON-CASH ITEM (B INR)

PAID INTEREST (M INR)

PAID TAXES (B INR)

Net Cash Flow from Operating Activities (B INR)NET CASH FLOW FROM OPERATING ACTIVITIES (B INR)

CAPITAL EXPENDITURES (M INR)

CASH FLOW FROM INVESTING ACTIVITIES (B INR)CASH FLOW FROM INVESTING ACTIVITIES (B INR)

CASH FLOW FROM OTHER INVESTING ACTIVITIES (B INR)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B INR)

INTEREST INCOME AND EXPENSES (M INR)

NET DEBT CHANGE (M INR)NET DEBT CHANGE (M INR)

Net change in equity (M INR)NET CHANGE IN EQUITY (M INR)

CASH FLOW FROM FINANCING ACTIVITIES (M INR)CASH FLOW FROM FINANCING ACTIVITIES (M INR)

OTHER ITEMS OF FINANCING CASH FLOWS (INR)CASH FLOW FROM OTHER FINANCING ACTIVITIES (INR)

TOTAL DIVIDENDS PAID (M INR)

NET CHANGE IN CASH FLOW (B INR)

FREE CASH FLOW (M INR)

SHARE-BASED COMPENSATION (M INR)

1999	2000	2001	2002	2003	2004	2005	2006	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
0.11	0.04	0.23	0.4	0.81	0.57	0.84	0.89	0.79	1.51	1.96	1.99	2.04	15.63	4.41	5.74	4.82	4.48	4.04	4.8	5.83	7.95	8.47	0	9.41	7.07
105	109	118	125	307	284	233	218	261	239	264	327	450	462	646	253	247	289	331	438	653	735	645	795	740	849
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-0.01	-0.15	0.46	-0.41	-0.34	0.16	-1.12	-0.79	0.2	-1.6	-1.45	-1.2	-1.38	-2.42	-1.57	-3.57	-2.53	-2.99	-3.2	1.87	-1.08	-1.7	-6.7	-3.8	-0.98	-5.17
0.03	0	-0.04	0.11	0.18	0.35	-0.07	0.04	0.15	0.2	0.04	0.1	-0.05	-12.29	-0.67	-0.41	-0.47	-0.21	0.05	0.24	1.25	-0.11	-0.25	-0.8	0.34	-0.13
236	276	292	205	205	85	57	73	58	104	121	85	17	20	15	9	48	12	41	53	24	28	42	112	78	85
0.02	0.05	0.03	0.2	0.21	0.3	0.36	0.33	0.72	0.45	0.73	0.56	0.74	1.23	1.6	1.91	1.65	1.48	0.95	2.05	1.36	1.63	2.64	2.4	1.32	1.62
0.24	0	0.77	0.21	0.96	1.36	-0.12	0.37	1.4	0.35	0.82	1.22	1.07	1.38	2.82	2	2.07	1.57	1.21	7.35	6.66	6.87	2.16	6.09	9.52	2.62
-222	-216	-239	-169	-434	-249	-461	-196	-558	-487	-816	-716	-583	-1,742	-1,619	-516	-403	-551	-437	-602	-413	-420	-554	-773	-457	-409
-0.19	-0.2	-0.21	-0.14	-0.13	-0.03	-0.34	-0.16	-0.25	-0.45	-0.79	1.95	0.89	4.27	-2.9	4.85	0.16	-0.08	0.38	-4.15	-0.29	0.07	0.64	0.83	0	0.86
0.03	0.02	0.03	0.03	0.3	0.22	0.12	0.04	0.31	0.04	0.03	2.67	1.47	6.01	-1.28	5.37	0.56	0.47	0.82	-3.55	0.12	0.49	1.2	1.61	0.46	1.27
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
104	193	-526	-102	-44	-1,465	406	-79	-389	-265	712	-55	-1,085	0	0	0	0	0	0	0	-228	-370	-263	-409	-418	-491
0	0	0	0	0	0	0	0	0	0	0	0	0	0	-4,550	0	-5,101	0	-5,049	0	0	0	0	0	0	0
59	148	-562	-340	-322	-1,649	249	-251	-558	-480	462	-324	-1,285	-213	-4,796	-415	-5,896	-733	-5,811	-1,583	-1,483	-5,558	-7,033	-6,132	-6,563	-6,194
-45.00	-45.00	-35.00	-238.00	-277.00	-183.00	-156.00	-172.00	-74.00	-120.00	-139.00	-111.00	-43.00	-47.00	-49.00	-68.00	-174.00	-134.00	-163.00	-322.00	-240.00	-28.00	-42.00	-112.00	-78.00	-95.00
0	0	0	0	0	0	0	0	-95	-94	-110	-158	-157	-166	-197	-347	-621	-599	-599	-1,261	-1,015	-5,160	-6,728	-5,611	-6,067	-5,608
0.11	-0.05	-0	-0.27	0.51	-0.31	-0.21	-0.04	0.6	-0.58	0.5	2.85	0.67	5.44	-4.88	6.44	-3.67	0.76	-4.21	1.62	4.89	1.38	-4.24	0.79	2.96	-2.72
12.3	-213.5	530.1	45.2	528.3	1,114.6	-579	169.5	845.6	-141.3	7.5	507	484	-359	1,196	1,488	1,662	1,022	777	6,744	6,246	6,447	1,601	5,320	9,059	2,211
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

API Docs Get API Key

Bayer Cropscience Stock Quarterly Figures

REVENUE (B INR)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (B INR)

NET INCOME (B INR)

NET INCOME GROWTH (%)

DIVIDEND (INR)DIV. (INR)

DIVIDEND GROWTH (%)DIV. GROWTH (%)

SHARES (M)

2004 Q1	2004 Q2	2004 Q3	2004 Q4	2005 Q1	2005 Q2	2005 Q3	2005 Q4	2007 Q1	2007 Q2	2007 Q3	2007 Q4	2008 Q4	2009 Q1	2009 Q2	2009 Q3	2009 Q4	2010 Q1	2010 Q2	2010 Q3	2010 Q4	2011 Q1	2011 Q2	2011 Q3	2011 Q4	2012 Q1	2012 Q2	2012 Q3	2012 Q4	2013 Q1	2013 Q2	2013 Q3	2013 Q4	2014 Q1	2014 Q2	2014 Q3	2014 Q4	2015 Q1	2015 Q2	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3e
1.09	1.41	3.01	2.28	1.27	1.48	2.25	2.42	1.42	3.32	5.15	2.24	1.88	4.95	4.35	3.08	2.44	6.02	5.07	3.86	2.3	7.21	6.51	5.31	2.35	7.9	7.3	4.99	2.54	9.21	8.27	5.88	3.9	9.88	10.5	6.54	5.53	12.01	12.41	7.12	5.7	7.97	10.55	5.69	4.68	8.56	11.6	6.95	2.38	7.37	12.32	4.8	3	9.06	12.34	7.75	2.52	9.5	13.46	8.54	4.59	12.28	13.82	9.18	7.34	14.16	13.65	9.9	9.63	16.67	14.52	10.38	9.83	17.4	16.17	9.55	7.92	16.31	17.38	10.57	10.48	19.15	15.53	11
–	30.14	112.89	-24.22	-44.12	16.34	51.79	7.65	-41.32	133.73	55.14	-56.44	-16.01	162.95	-12.17	-29.12	-21.01	147.04	-15.75	-23.96	-40.36	213.48	-9.71	-18.33	-55.87	236.93	-7.58	-31.72	-49.16	263.43	-10.26	-28.94	-33.55	153.00	6.35	-37.70	-15.54	117.24	3.36	-42.63	-20.00	39.96	32.36	-46.05	-17.85	82.92	35.59	-40.09	-65.75	209.71	67.14	-61.06	-37.42	201.83	36.18	-37.18	-67.46	276.84	41.66	-36.57	-46.29	167.67	12.53	-33.54	-20.09	92.98	-3.59	-27.47	-2.71	73.09	-12.92	-28.51	-5.34	77.06	-7.04	-40.95	-17.11	106.09	6.52	-39.17	-0.87	82.74	-18.87	-29.21
55.48	60.62	39.69	41.70	50.04	59.28	44.71	45.33	43.52	29.32	42.67	42.04	40.18	32.92	41.46	47.15	41.83	33.45	39.98	42.70	41.37	29.54	38.94	39.01	38.12	29.02	37.65	39.93	44.69	32.88	37.94	38.13	36.09	30.88	36.21	39.30	38.47	30.97	37.47	37.19	36.53	45.03	40.54	40.33	36.33	46.55	38.22	33.34	35.04	42.71	38.17	40.73	42.90	52.04	41.76	45.90	64.75	49.74	42.06	46.03	58.32	47.34	38.67	40.61	44.58	44.47	38.77	42.95	50.46	48.46	39.37	42.67	49.54	42.67	37.60	44.66	52.39	39.65	31.41	37.71	46.16	38.86	34.23	48.36
0.6	0.86	1.19	0.95	0.64	0.88	1.01	1.1	0.62	0.97	2.2	0.94	0.76	1.63	1.8	1.45	1.02	2.01	2.03	1.65	0.95	2.13	2.53	2.07	0.89	2.29	2.75	1.99	1.13	3.03	3.14	2.24	1.41	3.05	3.8	2.57	2.13	3.72	4.65	2.65	2.08	3.59	4.28	2.3	1.7	3.98	4.43	2.32	0.83	3.15	4.7	1.95	1.29	4.72	5.15	3.56	1.63	4.73	5.66	3.93	2.68	5.81	5.34	3.73	3.27	6.3	5.29	4.25	4.86	8.08	5.72	4.43	4.87	7.42	6.08	4.27	4.15	6.47	5.46	3.99	4.84	7.44	5.32	5.32
-0.02	0.08	0.28	-0.03	-0.02	0.05	0.27	0.08	-0.03	0.26	0.31	-0.06	-0.02	0.35	0.51	0.07	0.02	0.56	0.53	0.21	-0.04	0.49	0.64	0.36	-0.17	0.5	0.84	0.27	-0.22	0.89	0.98	9.03	0.72	0.88	1.17	0.39	0.46	1.09	1.76	0.55	0.43	1.11	1.56	0.29	0.19	1.31	1.59	0.37	-0.36	1.12	1.91	0.11	-0.13	1.64	1.67	0.63	-0.57	1.35	1.7	1.38	0.32	2.52	2.25	-0.45	0.62	2.54	1.54	0.85	1.53	3.03	1.63	1.35	1.59	3.29	2.23	0.93	0.96	2.54	1.36	0.34	1.43	2.79	1.53	0.15
–	-618.75	237.35	-111.43	-50.00	-425.00	419.23	-71.11	-133.33	-1,096.15	17.76	-118.36	-69.64	-2,141.18	47.26	-87.08	-69.70	2,700.00	-4.64	-59.93	-116.36	-1,502.86	30.35	-44.38	-148.03	-391.81	68.54	-68.25	-180.90	-510.65	10.37	822.78	-92.06	22.45	32.69	-66.52	18.46	134.85	62.30	-68.77	-21.09	154.84	40.87	-81.19	-33.79	576.29	21.27	-76.87	-198.10	-409.42	70.64	-94.39	-220.56	-1,373.64	1.52	-62.17	-190.49	-336.95	25.50	-18.79	-77.16	699.05	-10.77	-120.08	-237.25	309.85	-39.26	-44.97	80.07	98.17	-46.27	-17.28	17.84	107.26	-32.15	-58.23	3.11	164.79	-46.38	-74.91	319.01	94.49	-45.21	-89.91
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.00	-	-	-	4.00	-	-	-	4.20	-	-	-	5.00	-	-	-	5.50	4.00	-	-	17.00	-	-	-	17.00	-	-	-	17.00	-	-	-	18.00	-	-	-	18.00	-	-	-	25.00	-	-	-	25.00	-	-	-	25.00	-	100.00	-	30.00	-	105.00	-	35.00	-	90.00	-	35.00	-	90.00
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-27.27	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
39	39	40	39	39	39	40	39	39	39	40	40	39	40	40	40	39	39	39	40	40	40	39	39	39	39	39	39	40	39	39	39	39	39	39	37	44	37	37	37	37	37	37	35	38	35	35	35	35	35	34	34	36	34	34	34	35	34	34	45	45	45	45	45	45	45	45	45	45	45	45	45	44.94	44.94	44.94	44.93	44.94	44.94	44.94	44.94	44.94	44.94	44.94	44.94

Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Gross Margin

EBIT and EBIT Margin

Net Income and Earnings Per Share (EPS)

Shares Outstanding

Analyst Estimates

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

API Docs Get API Key

Bayer Cropscience stock margins

The Bayer Cropscience margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bayer Cropscience. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bayer Cropscience.

3 Years
5 Years
10 Years
25 Years
Max

Gross margin

EBIT margin

Profit margin

Details

API Docs Get API Key

Bayer Cropscience Stock Sales Revenue, EBIT, Earnings per Share

The Bayer Cropscience earnings per share therefore indicates how much revenue Bayer Cropscience has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

3 Years
5 Years
10 Years
25 Years
Max

Sales per Share

EBIT per share

Earnings per Share

Details

API Docs Get API Key

Bayer Cropscience business model

Bayer CropScience Ltd is a company specializing in the production and distribution of pesticides, seeds, and other agricultural products. It is headquartered in Monheim am Rhein, Germany, and is a part of the Bayer Group. The history of Bayer CropScience dates back to 1863 when it was founded by Friedrich Bayer and Johann Friedrich Weskott in Wuppertal, Germany. Initially, the company produced dyes before specializing in the production of chemicals and medicines. Over the years, the company began to expand into other areas, including agriculture. Today, Bayer CropScience is a leading global provider of agricultural chemical products and is among the top 3 companies in the global seed market. The company operates in more than 120 countries and employs over 23,000 people. The business model of Bayer CropScience involves developing and marketing innovative agricultural chemical products and seed varieties that help farmers increase their yields and improve their competitiveness. The company caters to all types of agricultural operations, from small family farms to large agricultural corporations. The company has various business segments, including seeds, plant protection products, pest control products, and digital agriculture solutions. In the seed segment, Bayer CropScience offers a wide range of seed varieties for various crops and geographies, including corn, soybeans, wheat, cotton, and vegetables. In the plant protection products segment, the company produces a variety of products that assist farmers in combating pests and weeds. Some of the most well-known products include Roundup, the most widely used herbicide globally, and Caparol, an insecticide for combating harmful insects on crops. In addition to plant protection products, Bayer CropScience also offers pest control products, including those used for combating mice, rats, and other rodents, as well as solutions for pest control in buildings and other structures. Another important business segment of Bayer CropScience is digital agriculture solutions. The company provides solutions for the digitalization of agricultural operations, which help farmers improve their productivity and efficiency. The offered solutions include software for optimizing cultivation strategies and precision application of plant protection products. In recent years, Bayer CropScience has also focused on the development of solutions for sustainable agriculture and environmental protection. The company aims to make agriculture more sustainable and environmentally friendly by offering innovative solutions for plant protection and seed development that are less harmful to the environment. Overall, Bayer CropScience is a key player in the global agricultural market, focusing on the development and marketing of innovative agricultural chemical products and seed varieties. The company offers a wide range of products and solutions for agriculture, which contribute to improving the productivity and efficiency of agricultural operations worldwide.

API Docs Get API Key

Bayer Cropscience SWOT Analysis

Strengths

Bayer Cropscience Ltd has a strong global presence, allowing it to tap into diverse markets and benefit from economies of scale in its operations. The company's extensive range of innovative crop protection products and agricultural solutions gives it a competitive edge in the industry. Bayer Cropscience also boasts a robust research and development capability, allowing it to continuously innovate and meet the evolving needs of farmers and consumers. Furthermore, its strong brand reputation and customer loyalty provide a solid foundation for growth.

Weaknesses

One of the main weaknesses of Bayer Cropscience Ltd is its heavy dependence on chemical-based products. With increasing consumer awareness about the potential environmental and health impacts of such products, the company faces the risk of declining demand or regulatory restrictions. Moreover, certain regions may have specific regulations or cultural preferences that limit the adoption of Bayer Cropscience's offerings. Additionally, the company's high reliance on a few key customers may pose a vulnerability to its revenue streams if those relationships were to weaken.

Opportunities

Bayer Cropscience Ltd has the opportunity to leverage its expertise in biotechnology and digital agriculture to expand into emerging markets and diversify its product portfolio. The increasing global population and changing consumption patterns create a growing demand for sustainable agricultural solutions, which the company can capitalize on. Furthermore, strategic partnerships and acquisitions can provide avenues for growth and access to new technologies. The company can also explore opportunities in organic farming and precision agriculture, aligning with the shifting preferences of consumers.

Threats

Bayer Cropscience Ltd operates in a highly competitive market, facing threats from both traditional and new entrants. Intense competition can put pressure on pricing and erode profit margins. Additionally, the company is susceptible to the risks associated with climate change, such as extreme weather events and changing pest patterns. Heightened public scrutiny on the environmental and health impacts of agricultural practices poses a reputational risk. Moreover, evolving regulatory landscapes and trade policies may impact the company's ability to operate globally and limit market access.

API Docs Get API Key

Bayer Cropscience Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

API Docs Get API Key

Bayer Cropscience historical P/E ratio, EBIT multiple, and P/S ratio

API Docs Get API Key

Bayer Cropscience shares outstanding

The number of shares was Bayer Cropscience in 2025 — This indicates how many shares 44.942 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

3 Years
5 Years
10 Years
25 Years
Max

Number of stocks

Details

API Docs Get API Key

Bayer Cropscience Dividend History

16 years of dividend payments

YearAnnual DividendYoY ChangePayments

2025125INR 0.0%2×

Aug 7, 202535INR↓ 61.1%1/2

Nov 14, 202590INR↑ 157.1%2/2

2024125INR↓ 7.4%2×

2023135INR↑ 8.0%2×

API Docs Get API Key

Bayer Cropscience dividend history and estimates

In 2025, Bayer Cropscience paid a dividend amounting to 125 INR. Dividend means that Bayer Cropscience distributes a portion of its profits to its owners.

Dividend

Dividend (Estimate)

Special dividend

Details

API Docs Get API Key

Bayer Cropscience dividend payout ratio

In 2025, Bayer Cropscience had a payout ratio of 103.31%. The payout ratio indicates the percentage of the company's profits that Bayer Cropscience distributes as dividends.

3 Years
5 Years
10 Years
25 Years
Max

Payout ratio

Details

API Docs Get API Key

Unfortunately, there are currently no price targets and forecasts available for Bayer Cropscience.

API Docs Get API Key

EESG©

Eulerpool ESG Scorecard© for the Bayer Cropscience stock

81/100

Environment

Social

Governance

Environment

Scope 1 - Direct Emissions976.41

Scope 2 - Indirect emissions from purchased energy3,108.69

Scope 3 - Indirect emissions within the value chain8,860,000

Total CO₂ emissions4,085.1

CO₂ reduction strategy

Coal energy

Nuclear power

Animal experiments

Fur & Leather—

Pesticides

Palm Oil—

Tobacco

Genetically modified organisms

Climate concept—

Sustainable forestry—

Recycling regulations

Environmentally friendly packaging

Hazardous substances

Fuel consumption and efficiency

Water consumption and efficiency

Social

Percentage of female employees22

Percentage of women in management—

Percentage of Asian employees—

Share of Asian management—

Percentage of Hispanic/Latino employees—

Hispano/Latino Management share—

Percentage of Black employees—

Black Management Share—

Percentage of white employees—

White Management Share—

Adult content

Alcohol

Weapons—

Firearms

Gambling

Military contracts

Human rights concept

Privacy concept—

Occupational health and safety

Catholic

Governance (Corporate Governance)

Environmental reporting

Stakeholder Engagement

Call Back Policies

Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

API Docs Get API Key

Bayer Cropscience shareholders

%	Name	Stocks	Change	Date
67.99501%	Bayer Group	30,558,386	-1,544,613	3/31/2025
3.43690%	Monsanto Co	1,544,613	+1,544,613	3/31/2025
2.32284%	Quant Money Managers Ltd	1,043,933		3/31/2025
2.11312%	Nippon Life India Asset Management Limited	949,680	+601	7/31/2025
2.02923%	Aditya Birla Sun Life AMC Limited	911,978	-55,563	3/31/2025
1.04398%	Indian Syntans Investments Pvt. Ltd.	469,185		3/31/2025
1.01715%	HDFC Life Insurance Company Limited	457,127	-53,427	3/31/2025
0.86777%	The Vanguard Group, Inc.	389,992		7/31/2025
0.63066%	Bandhan Asset Management Company Limited	283,431	-13,979	7/31/2025
0.46973%	BlackRock Institutional Trust Company, N.A.	211,106	+3,988	7/31/2025
0.27426%	Investor Education Protection Fund	123,260	-462	3/31/2025
0.21512%	Dimensional Fund Advisors, L.P.	96,679	+888	7/31/2025
0.20271%	DSP Investment Managers Pvt. Ltd.	91,103	+196	7/31/2025
0.18534%	HDFC Asset Management Co., Ltd.	83,297	+14,003	7/31/2025
0.17365%	Canara Robeco Asset Management Company Ltd.	78,040		7/31/2025
0.16568%	HSBC Global Asset Management (India) Private Limited	74,462		7/31/2025
0.13013%	Bank of India Investment Managers Private Limited	58,483	+9,940	7/31/2025
0.08923%	BlackRock Advisors (UK) Limited	40,104	+102	6/30/2025
0.08340%	Kotak Mahindra Asset Management Company Limited	37,483	-13,852	7/31/2025
0.07529%	Mellon Investments Corporation	33,839	-562	7/31/2025
0.06369%	Franklin Templeton Portfolio Advisors, Inc	28,622	+518	7/31/2025
0.05996%	State Street Global Advisors (UK) Ltd.	26,948	+1,222	7/31/2025
0.05249%	American Century Investment Management, Inc.	23,589	+3,852	7/31/2025
0.05091%	California Public Employees' Retirement System	22,881	+314	6/30/2024
0.04895%	Baroda BNP Paribas Asset Management India Pvt. Ltd.	22,000	+22,000	7/31/2025
0.04756%	PGGM Vermogensbeheer B.V.	21,375	+110	3/31/2025
0.04728%	NJ Asset Management Private Limited	21,247	+321	7/31/2025
0.04545%	JM Financial Asset Management Pvt. Ltd.	20,424	-3,448	7/31/2025
0.04414%	State Street Global Advisors (US)	19,838	+246	7/31/2025
0.04114%	State Street Global Advisors Ireland Limited	18,491	-562	11/30/2024
0.03975%	Charles Schwab Investment Management, Inc.	17,863		7/31/2025
0.03088%	Dimensional Fund Advisors, Ltd.	13,877	+329	6/30/2025
0.02805%	Mirae Asset Global Investments (India) Pvt. Ltd.	12,606	+385	7/31/2025
0.02524%	Nuveen LLC	11,343		4/30/2025
0.02297%	SBI Funds Management Pvt. Ltd.	10,321	+135	7/31/2025
0.02225%	Sundaram Asset Management Company Limited	10,000		7/31/2025
0.02129%	BlackRock Investment Management (UK) Ltd.	9,570		3/31/2025
0.01992%	LIC Mutual Fund Asset Management Company Ltd.	8,951		7/31/2025
0.01969%	Motilal Oswal Asset Management Company Ltd.	8,848	+260	7/31/2025
0.01508%	Geode Capital Management, L.L.C.	6,777		6/30/2025
0.01306%	Legal & General Investment Management Ltd.	5,869		6/30/2025
0.01246%	SEI Investments Management Corporation	5,600	+5,600	6/30/2025
0.01178%	California State Teachers Retirement System	5,295	+5,295	6/30/2024
0.00819%	ICICI Prudential Asset Management Co. Ltd.	3,683	-37,123	7/31/2025
0.00543%	Probus Middle East Limited	2,440	-2,160	6/30/2024
0.00456%	DFA Australia Ltd.	2,050		7/31/2025
0.00446%	Vanguard Investments Australia Ltd.	2,004		6/30/2025
0.00374%	Vanguard Global Advisers LLC	1,681		6/30/2025
0.00358%	Invesco Capital Management LLC	1,608	-54	7/31/2025
0.00281%	Franklin Advisers, Inc.	1,264	+480	6/30/2025
0.00234%	HSBC Global Asset Management (UK) Limited	1,050		5/31/2025
0.00219%	Edelweiss Asset Management Ltd.	985	+51	7/31/2025
0.00216%	Groww Asset Management Ltd	971	+23	7/31/2025
0.00050%	Dimensional Fund Advisors Canada ULC	223		3/31/2025
0.00031%	CI Global Asset Management	140	-1	6/30/2025
0.00027%	Asset Management One Co., Ltd.	120	+120	11/30/2024
0.00011%	Franklin Templeton Institutional, LLC	48		7/31/2025
0.00011%	Franklin Advisory Services, LLC	48		3/31/2025
0.00010%	Northern Trust Investments, Inc.	47		7/31/2025
0.00000%	Wellington Management Company, LLP	1	+1	4/30/2025
%	White Oak Capital Management Consultants Llp		-14,629	10/31/2024
%	Mahindra Manulife Investment Management Private Limited		-12,879	5/31/2025
%	360 ONE Asset Management Limited		-5,892	5/31/2024
%	Navi AMC Limited		-909	3/31/2025
%	Axis Asset Management Company Limited		-19,522	4/30/2024
%	Mirae Asset Global Investments (Hong Kong) Limited		-80,265	9/30/2024
%	Mirae Asset Global Investments Co., Ltd.		-6,068	12/31/2024
%	Scottish Equity Partners LLP		-387	3/31/2025
%	Taurus Asset Management Co. Ltd.		-2,461	1/31/2024
%	Tata Asset Management Ltd.		-58,500	2/28/2025
%	Maybank Asset Management Sdn. Bhd.		-5,959	8/31/2024
%	Boston Partners		-513	5/31/2024
%	State Street Global Advisors Australia Ltd.		-153	9/30/2024
%	UTI Asset Management Co. Ltd.		-5,659	6/30/2025
%	PGIM Quantitative Solutions LLC		-110	12/31/2023
%	Van Eck Associates Corporation		-9,044	3/31/2024
%	Avantis Investors_NLE		-543	3/31/2025
%	WhiteOak Capital Asset Management Limited		-11,584	10/31/2024

...

API Docs Get API Key

Bayer Cropscience Executives and Management Board

Mr. Simon-Thorsten Wiebusch

Chief Executive Officer, Executive Vice Chairman, Managing Director · since 2021

Compensation86.05 MINR

Compensation86.05 M INR

Dr. Thomas Hoffmann

(53)

Non-Executive Non-Independent Director · since 2013

39.14 MINR

Compensation39.14 M INR

Mr. Sekhar Natarajan

Non-Executive Independent Director

2.35 MINR

Compensation2.35 M INR

Mr. Pankaj Patel

Non-Executive Independent Chairman of the Board

1.88 MINR

Compensation1.88 M INR

Mr. Vinit Jindal

Chief Financial Officer, Additional Whole-Time Director · since 2025

API Docs Get API Key

Bayer Cropscience Research

Soon

Deep-dive analyses, investment theses, and proprietary research — curated by Eulerpool.

Research reports are coming soon

We're building institutional-grade equity research for Bayer Cropscience and thousands of other companies.

Most common questions regarding Bayer Cropscience

The business model of Bayer Cropscience Ltd revolves around the production and marketing of innovative solutions for agriculture and environmental science. As a leading global player in the crop protection and seeds industry, Bayer Cropscience focuses on developing advanced crop production technologies and breeding high-quality seeds to enhance agricultural productivity and sustainability. By leveraging its expertise in science and research, the company aims to provide farmers with effective pest control and disease management solutions, improve crop yields, and contribute to global food security. This commitment to innovation and sustainability drives Bayer Cropscience's efforts to support and empower farmers worldwide.

API Docs Get API Key

Fair ValuePRO

4,307.4 INR

Over-/UndervaluationPRO

22.0% undervalued

Expected Return

8.51 %

Sector

Commodities

Industry

Fertilizers & Agricultural Chemicals

Number of shares

44,942,100

Employees

1,318

Revenue per Employee

41.53 M INR

Revenue growth Ø5 years

5.13 %

EBIT growth Ø5 years

-3.74 %

Net Income growth Ø5 years

2.87 %

Website bayer.in

Country

India 🇮🇳

Currency

INR

Initial public offering

Jan 8, 2010

ISIN

INE462A01022

Cusip

Y0761E135

Sedol

6716992

Market capitalization

210.37 B INRMega Cap

52-Week Range

4,415.4–4,830INR

Bayer Cropscience Directors Dealings

Quality Investing

Details

5 / 10

Sales growth (10Y) > 5%

Revenue growth (3Y) > 5 %

EBIT growth (10Y) > 5%

EBIT growth (3Y) > 5 %

Net debt < 4x EBIT

Profitable since 10Y+

EBIT Drawdown (10Y) < 50%

Return on Equity (ROE) > 15%

ROCE > 15%

Return Expectation > 10%

PEG

3.92

P/E ratio

37.87

P/Ee 2026

33.08

P/Ee 2027

28.54

P/Ee 2028

25.09

P/S

3.93

P/Se

3.73

EV/EBIT

32.99

P/B Ratio

7.38

ROE (Return on Equity)

19.93 %

ROA (Return on Assets)

10.83 %

ROCE (Return on Capital Employed)

21.74 %

ROIC (Return on Invested Capital)

25.18 %

PROUnlock all valuation metrics

Gross Margin

36.93 %

EBIT Margin

11.32 %

Net Margin

10.38 %

EPS (Earnings Per Share)

126.38 INR

Net Debt / EBIT

-0.96

Debt/Equity

0.04

Dividend

125 INR

Dividend yield

2.61 %

Est. Dividend Yield

2.61 %

Payout Ratio

103.31 %

Dividend growth Ø5Y

-3.58 %

Dividend payments per year

Dividend paid since

14 years+

Dividend not reduced since

2 years

Dividend increased since

0 years

Dividend withholding tax

20 %

Last updated Mar 3, 2026, 12:14 PM

Bayer Cropscience Peer Group

Bayer Cropscience Ticker

BSE · BAYERCROP.BONEW YORK · BAYERCROP.NS

Bayer Cropscience FIGI

BYRCS:IN · BBG000CP0P31BYRCS:IB · BBG000CP0PH6BYRCS:IS · BBG000CP0RC7BYRCS:IG · BBG003NVW1N6

All fundamentals about Bayer Cropscience

Our stock analysis for Bayer Cropscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bayer Cropscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Bayer Cropscience Revenue→

Bayer Cropscience Net Income→

Bayer Cropscience P/E→

Bayer Cropscience P/S→

Bayer Cropscience EBIT→

Bayer Cropscience Dividend→

Bayer Cropscience Directors Dealings→

Bayer Cropscience Stocks→

Bayer Cropscience Market capitalization→

Bayer Cropscience Debt→

Bayer Cropscience Liabilities→

Bayer Cropscience Equity→